跳至主要内容
临床试验/CTRI/2022/05/042508
CTRI/2022/05/042508已完成未知

An observational, comparative study to understand the difference in scalp physiological parameters in males and females suffering with male pattern baldness and female pattern hair loss.

Marico Limited0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Age: 18 to 45 years (both inclusive) at the time of consent.
  • 2. Sex: Healthy male or non-pregnant/non-lactating/pre-menopausal female.
  • 3. Subjects generally in good health.
  • 4. 12 Subjects (males and females) without any pattern baldness / pattern hair loss.
  • 5. Female subjects of childbearing potential must have a negative urine pregnancy test performed on screening visit and Enrollment.
  • 6. Subjects having hair density of >100 and <200 hair per cm2.
  • 7. 6 Female subjects with hairfall condition:
  • a.Subjects complaining of hair fall and onset of baldness.
  • b.Subjects falling under Type 2 - Type 3 of hair loss severity grade evaluated as per Ludwig scale.
  • 8. 6 Male subjects with hairfall condition:
  • a.Subjects complaining of hair fall and damage.
  • b.Subjects falling under Type 3 - Type 6 of hair loss severity grade evaluated as per Norwood Scale for male pattern hair loss.
  • 9. Subjects who are non-oil users.
  • 10. Subjects willing to give written informed consent and willing to follow study procedure.
  • 11. Subjects must be able to understand and provide written informed consent to participate in the study.
  • 12. Subjects should be willing and able to follow the study protocol to participate in the study.
  • 13. Subjects willing to refrain from using other products on the scalp other than those provided, including other shampoos/conditioners, scalp and hair treatment and oils/ products that has anti-dandruff action during the study period.
  • 14. Subjects completing the conditioning phase.
  • 15. Subjects willing to use test product throughout the study period.

排除标准

  • 1. Subjects who have undergone hair growth treatment within 3 months before screening into the study.
  • 2. Subjects having any active scalp disease which may interfere in the study.
  • 3. Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
  • 4. Subjects who have history of alcoholism, smoking, crash dieting and/ or psychiatric disorder including trichotillomania.
  • 5. Subjects who have had hair transplant, who have taken pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia, under medical treatment for hair problems.
  • 6. Subjects having known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
  • 7. Subjects on oral medications, undergoing any chemical hair salon treatment-straightening / perming / colour / henna which will compromise the study.
  • 8. Subjects with chronic illness which may influence the cutaneous state.
  • 9. Subjects participating in other similar cosmetic or therapeutic trial within last three months.
  • 10. Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
  • 11. Subjects who have not used anti-dandruff, anti-bacterial, anti-fungal products on their scalps for atleast the past 1 month.
  • 12. Female subjects pregnant or lactating or having menstrual and obstetric disorders.
  • 13. Any other condition which could warrant exclusion from the study, as per the Dermatologistâ??s/investigatorâ??s discretion.

研究者

相似试验